Article
The uptake of best-value medicines across England -- a mixed method study
2026-04-02
Abstract excerpt
reprint, amsmath,amssymb, aps, ]revtex4-2 <h4>Background: </h4> The rapid adoption of best-value biosimilars and generics improves cost-effectiveness of treatment and increases patient access. Despite this, adoption differs among hospitals. <h4>Objectives: </h4> To quantify variation in adoption among English teaching hospitals, estimate the financial impact of delays, and identify factors influencing uptake. <...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2df8d31b-858f-5ae6-b95c-62e009cf65ca
- DOI
- 10.22541/au.177511713.35479395/v1
